Search
for
Sort by
Research 211–240 of 1000+
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Therapeutic Androgen Receptor Ligands
- Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors
- Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors
- Clinical use of 5α-reductase inhibitors
- Isolated depressive disorders and suicidality with finasteride use for androgenetic alopecia: a call for enhanced vigilance
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- Referee report. For: Exploring the use of phytotherapy in benign prostatic hyperplasia [BPH]: a systematic review [version 1; peer review: 2 approved with reservations]
- Steroid Hormones of Reproduction and Sexual Development
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Cancer risk by the subtype of alopecia
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- 5-Alpha-reductase deficiency in a Saudi "girl"
- A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Medical consequences of long-term anabolic-androgenic Steroids (AASs) abuses in athletes
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- 516 Functional annotation of genes underlying hair disorders
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- Diseases of the Canine Prostate Gland
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Is dehydroepiandrosterone a hormone?
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Structure of human type II 5 alpha-reductase gene.
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>